These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 31846123)

  • 1. Quantitative evaluation of iron content in idiopathic rapid eye movement sleep behavior disorder.
    Sun J; Lai Z; Ma J; Gao L; Chen M; Chen J; Fang J; Fan Y; Bao Y; Zhang D; Chan P; Yang Q; Ye C; Wu T; Ma T
    Mov Disord; 2020 Mar; 35(3):478-485. PubMed ID: 31846123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Application of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Techniques to Investigate the Effect of Iron Deposition on Microstructural Changes in the Brain in Parkinson's Disease.
    Yang L; Cheng Y; Sun Y; Xuan Y; Niu J; Guan J; Rong Y; Jia Y; Zhuang Z; Yan G; Wu R
    Front Aging Neurosci; 2022; 14():792778. PubMed ID: 35370619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
    Iranzo A; Lomeña F; Stockner H; Valldeoriola F; Vilaseca I; Salamero M; Molinuevo JL; Serradell M; Duch J; Pavía J; Gallego J; Seppi K; Högl B; Tolosa E; Poewe W; Santamaria J;
    Lancet Neurol; 2010 Nov; 9(11):1070-7. PubMed ID: 20846908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of iron overload in nigrosome 1 via quantitative susceptibility mapping as a progression biomarker in prodromal stages of synucleinopathies.
    Lancione M; Donatelli G; Del Prete E; Campese N; Frosini D; Cencini M; Costagli M; Biagi L; Lucchi G; Tosetti M; Godani M; Arnaldi D; Terzaghi M; Provini F; Pacchetti C; Cortelli P; Bonanni E; Ceravolo R; Cosottini M
    Neuroimage; 2022 Oct; 260():119454. PubMed ID: 35810938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
    He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
    Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.
    Stokholm MG; Iranzo A; Østergaard K; Serradell M; Otto M; Svendsen KB; Garrido A; Vilas D; Borghammer P; Santamaria J; Møller A; Gaig C; Brooks DJ; Tolosa E; Pavese N
    Lancet Neurol; 2017 Oct; 16(10):789-796. PubMed ID: 28684245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole brain pattern of iron accumulation in REM sleep behavior disorder.
    Varga Z; Keller J; Robinson SD; Serranova T; Nepozitek J; Zogala D; Trnka J; Ruzicka E; Sonka K; Dusek P
    Hum Brain Mapp; 2024 Apr; 45(5):e26675. PubMed ID: 38590155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Free Water in the Putamen in Idiopathic REM Sleep Behavior Disorder.
    Zhang D; Zhou L; Yao J; Shi Y; He H; Wei H; Tong Q; Liu J; Wu T
    Mov Disord; 2023 Sep; 38(9):1645-1654. PubMed ID: 37342973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic Resonance Imaging Biomarkers to Assess Substantia Nigra Damage in Idiopathic Rapid Eye Movement Sleep Behavior Disorder.
    Pyatigorskaya N; Gaurav R; Arnaldi D; Leu-Semenescu S; Yahia-Cherif L; Valabregue R; Vidailhet M; Arnulf I; Lehéricy S
    Sleep; 2017 Nov; 40(11):. PubMed ID: 28958075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased free water in the substantia nigra in idiopathic REM sleep behaviour disorder.
    Zhou L; Li G; Zhang Y; Zhang M; Chen Z; Zhang L; Wang X; Zhang M; Ye G; Li Y; Chen S; Li B; Wei H; Liu J
    Brain; 2021 Jun; 144(5):1488-1497. PubMed ID: 33880500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder.
    Iranzo A; Stockner H; Serradell M; Seppi K; Valldeoriola F; Frauscher B; Molinuevo JL; Vilaseca I; Mitterling T; Gaig C; Vilas D; Santamaria J; Högl B; Tolosa E; Poewe W
    Mov Disord; 2014 Dec; 29(14):1774-80. PubMed ID: 25384461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron accumulation in the ventral tegmental area in Parkinson's disease.
    Zhang D; Yao J; Sun J; Wang J; Chen L; He H; Wu T
    Front Aging Neurosci; 2023; 15():1187684. PubMed ID: 37448687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of the substantia nigra echogenicity and
    Mašková J; Školoudík D; Štofaniková P; Ibarburu V; Kemlink D; Zogala D; Trnka J; Krupička R; Šonka K; Růžička E; Dušek P
    Sleep Med; 2020 Jun; 70():116-123. PubMed ID: 32403038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson's disease.
    Biondetti E; Gaurav R; Yahia-Cherif L; Mangone G; Pyatigorskaya N; Valabrègue R; Ewenczyk C; Hutchison M; François C; Arnulf I; Corvol JC; Vidailhet M; Lehéricy S
    Brain; 2020 Sep; 143(9):2757-2770. PubMed ID: 32856056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI quantitative susceptibility mapping of the substantia nigra as an early biomarker for Lewy body disease.
    Chen Q; Boeve BF; Forghanian-Arani A; Senjem ML; Jack CR; Przybelski SA; Lesnick TG; Kremers WK; Fields JA; Schwarz CG; Gunter JL; Trzasko JD; Graff-Radford J; Savica R; Knopman DS; Dickson DW; Ferman TJ; Graff-Radford N; Petersen RC; Kantarci K
    J Neuroimaging; 2021 Sep; 31(5):1020-1027. PubMed ID: 34033185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
    Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
    BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
    Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
    Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Susceptibility Mapping and Free Water Imaging of Substantia Nigra in Parkinson's Disease.
    Zhang D; Yao J; Sun J; Tong Q; Zhu S; Wang J; Chen L; Ma J; He H; Wu T
    J Parkinsons Dis; 2022; 12(8):2469-2478. PubMed ID: 36404557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Susceptibility Mapping in Parkinson's Disease.
    Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
    PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.